After analyzing data from a large patient cohort, researchers in Taiwan now conclude that the method by which the bladder cuff is removed has no effect on cancer-specific outcomes. The number of ...

South San Francisco, California Friday, March 28, 2025, 14:00 Hrs [IST] ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

The risk group is really large According to data from the National Cancer Registry, approximately 8,000 new cases of bladder cancer are diagnosed in Poland each year. This problem mainly affects ...

Veracyte (VCYT) announced new data showing that its whole-genome sequencing-based platform for minimal residual disease testing detected cancer ...

The findings, from the large, independent ... methods for monitoring minimal residual disease in patients with bladder cancer: Insights from the TOMBOLA Trial"). The new study involved 100 ...

Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...

High-risk, non-muscle-invasive bladder cancer is defined as any transitional cell carcinoma (TCC) of the bladder that is high-grade, whether it is primary or recurrent. This high-risk group ...

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).